Skip to content
Open access

Shared and Specific miRNA-mRNA in Human and Murine Acute Kidney Injury

Oct 2026 · bioRxiv · 0 citations · 68 references
Medicine Biology

TL;DR

Integration of injury etiology, severity, and time may provide a framework for developing circulating biomarkers that may resolve the biological heterogeneity of human AKI.

Abstract

Acute kidney injury (AKI) is managed as a single clinical entity despite substantial biological heterogeneity. We established a cross-species framework to define etiology-specific molecular programs and determine how these programs relate to molecular heterogeneity and pathobiology in human AKI. We performed parallel sequencing of totalRNA (mRNA) and miRNA (kidney, whole blood) in 3 murine models (mild AKI: ischemia-reperfusion injury, IRI; cecal-ligation and puncture, CLP; endotoxemia, LPS); kidney mRNA and miRNA clearly distinguished the models, blood mRNA maintained model-specific separation, and blood miRNA was less distinct. IRI was characterized by epithelial injury/repair, and extracellular matrix remodeling (i.e., miR-125b-1-3p, Vim, Sprr2g); CLP, broader inflammatory, metabolic programs (i.e., miR-692, Pfkfb3, Cdo1); LPS, inflammatory signaling (i.e., miR-155-5p, Irf7, Gbp3). We then compared these signatures to human whole blood RNAseq. Human blood samples varied along a shared gene axis that correlated to differing degrees with all three murine models, consistent with the heterogeneous nature of clinical AKI rather than discrete assignment to a single experimental etiology. Orthologs were linked to immune processes (i.e., SIGLEC14, DAAM2, CD177, DEFA3), and the presence of tubular casts in human biopsies, reflecting that mild murine AKI models capture etiology-specific biology relevant to severe human AKI. Integration of injury etiology, severity, and time may provide a framework for developing circulating biomarkers that may resolve the biological heterogeneity of human AKI.

Read PDF

Similar papers

Oct 2026

MicroRNA-34b-5p Modulates Sepsis-Induced Acute Kidney Injury via the LMX1B/HIGD1A Axis: Implications for Molecular Therapeutics

Background: Sepsis-induced acute kidney injury (AKI) represents a critical complication with high mortality, largely due to the absence of specific targeted treatments MicroRNAs (miRNAs) are emerging as critical regulators in AKI pathogenesis, but their specific molecular mechanisms and biotechnological applications re...

Hong Shao, Sheng Xu, Bin Du et al. · 0 citations
Open access Nov 2026

Early Renal microRNA Signatures of Septic Acute Kidney Injury in Neonatal Pigs.

Acute kidney injury (AKI) is a major complication of neonatal sepsis, yet the early molecular events underlying sepsis-associated AKI (SA-AKI) in the maturing kidney remain poorly defined. MicroRNAs (miRNAs) are post-transcriptional regulators of gene expression that may contribute to the inflammatory, stress, and remo...

Ayodeji E. Adepoju, Mina S. Fanous, O. Michael et al. · 0 citations
Review Open access Oct 2026

Pathophysiological Insights of KIM-1 in Sepsis-Associated Acute Kidney Injury: Insights into the molecular mechanism: A Narrative Review

BACKGROUND: Sepsis-associated acute kidney injury (S-AKI) represents a major clinical challenge, characterized by high incidence, poor prognosis, and limited diagnostic precision with traditional markers such as serum creatinine and urine output. Kidney Injury Molecule-1 (KIM-1), encoded by HAVCR1 on chromosome 5q33.3,...

Shiv K. Sharma, S. Kukreja, Parminder Singh et al. · 0 citations
Open access Oct 2026

A cell-free therapeutic strategy using MSC-derived exosomes and activated platelet lysate for acute kidney injury induced by rhabdomyolysis

Rhabdomyolysis-induced acute kidney injury (AKI) is primarily driven by myoglobin-mediated tubular toxicity, leading to pronounced oxidative stress, inflammation, and apoptosis. Given the limited availability of effective targeted therapies, this study aimed to evaluate the efficacy of a combined cell-free approach usi...

Neveen A. Salem, Shaimaa A. ElShebiney, E. Salem et al. · 0 citations
Open access Oct 2026

Macrophage-derived FKBP5 exacerbates myocardial injury post-infarction in chronic kidney disease via the HSP90/HIF-1α signaling pathway

Chronic kidney disease (CKD) is a frequent and lethal comorbidity in patients with acute myocardial infarction (AMI). This study aimed to quantify the clinical impact of CKD on post-MI outcomes and investigate the molecular mechanisms of cardiorenal crosstalk involving FKBP5. We analyzed MI populations fro...

W. Zhang, X. Gao, J.-M. Chen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.